M

Magle Chemoswed Holding AB
STO:MAGLE

Watchlist Manager
Magle Chemoswed Holding AB
STO:MAGLE
Watchlist
Price: 32.6 SEK -4.12% Market Closed
Market Cap: 599.9m SEK
Have any thoughts about
Magle Chemoswed Holding AB?
Write Note

Magle Chemoswed Holding AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Magle Chemoswed Holding AB
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
M
Magle Chemoswed Holding AB
STO:MAGLE
Operating Income
kr21.7m
CAGR 3-Years
69%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Operating Income
kr805m
CAGR 3-Years
5%
CAGR 5-Years
36%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Operating Income
-kr100m
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Operating Income
kr351m
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
22%
G
Genovis AB
STO:GENO
Operating Income
kr23.2m
CAGR 3-Years
41%
CAGR 5-Years
31%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Operating Income
kr294.3m
CAGR 3-Years
38%
CAGR 5-Years
33%
CAGR 10-Years
32%
No Stocks Found

Magle Chemoswed Holding AB
Glance View

Market Cap
599.9m SEK
Industry
Life Sciences Tools & Services

Magle Chemoswed Holding AB engages in the provision of contract development and manufacturing services to the pharmaceutical and medical device industry. The company is headquartered in Malmo, Skane. The company went IPO on 2020-06-30. The firm's operations are mainly conducted through the subsidiaries Magle Chemoswed AB and Adroit Science AB. The business is focused on process development and manufacturing of Active Pharmaceutical Ingredients (API) as well as research, development and manufacturing of products in the areas of wound care and diagnostics with particular focus on products based on degradables starch microspheres. Magle Chemoswed also functions as a consultancy in material characterization and solid phase analysis with a main focus on pharmaceutical companies.

MAGLE Intrinsic Value
83.52 SEK
Undervaluation 61%
Intrinsic Value
Price
M

See Also

What is Magle Chemoswed Holding AB's Operating Income?
Operating Income
21.7m SEK

Based on the financial report for Dec 31, 2023, Magle Chemoswed Holding AB's Operating Income amounts to 21.7m SEK.

What is Magle Chemoswed Holding AB's Operating Income growth rate?
Operating Income CAGR 3Y
69%

Over the last year, the Operating Income growth was 69%. The average annual Operating Income growth rates for Magle Chemoswed Holding AB have been 69% over the past three years .

Back to Top